APA

Lüdemann J., Dütting E. D. & Dworak M. (20150824). Patient preference and tolerability of a DPP-4 inhibitor versus a GLP-1 analog in patients with type 2 diabetes mellitus inadequately controlled with metformin: a 24-week, randomized, multicenter, crossover study. : Therapeutic advances in endocrinology and metabolism.

Chicago

Lüdemann Jörg, Dütting Eva D and Dworak Markus. 20150824. Patient preference and tolerability of a DPP-4 inhibitor versus a GLP-1 analog in patients with type 2 diabetes mellitus inadequately controlled with metformin: a 24-week, randomized, multicenter, crossover study. : Therapeutic advances in endocrinology and metabolism.

Harvard

Lüdemann J., Dütting E. D. and Dworak M. (20150824). Patient preference and tolerability of a DPP-4 inhibitor versus a GLP-1 analog in patients with type 2 diabetes mellitus inadequately controlled with metformin: a 24-week, randomized, multicenter, crossover study. : Therapeutic advances in endocrinology and metabolism.

MLA

Lüdemann Jörg, Dütting Eva D and Dworak Markus. Patient preference and tolerability of a DPP-4 inhibitor versus a GLP-1 analog in patients with type 2 diabetes mellitus inadequately controlled with metformin: a 24-week, randomized, multicenter, crossover study. : Therapeutic advances in endocrinology and metabolism. 20150824.